Jing Wang

Oncology · Cancer Discovery · 2011–2021

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Jing Wang trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Pardoll (in Oncology)

Papers from Jing Wang's perspective

Ordered by how strongly the researchers Jing Wang trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  2. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  3. Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
  4. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. (Genome Research)
  5. Loss of PTEN promotes resistance to T cell-mediated immunotherapy (Cancer Discovery)
  6. Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates (Journal of Clinical Oncology)
  7. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity (Nature)
  8. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia
  9. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. (Cancer Research)
  10. Systematic identification of genomic markers of drug sensitivity in cancer cells (Nature)

Their papers